Anand Balakrishnan

Presenting Author
Enanta Pharmaceuticals, Inc

Disclosure information not submitted.

Presentation(s):

• 340 - Chemical biology and drug discovery in infectious disease

  Monday, April 4, 2022
  4:30 PM – 5:30 PM

• 500.1 - Molecular Basis for Antiviral Action of EDP-235: A Potent and Selective SARS-CoV-2 3CLpro Inhibitor for the Treatment of Covid 19

  Monday, April 4, 2022
  4:30 PM – 4:45 PM